4 research outputs found

    New Ruthenium (III) complexes with antitumor activity: design, synthesis and characterization

    No full text
    Cisplatin was introduced in 1978 in clinical practice for the cancer treatment. In spite of the highly successful use of this drug, it shows several side effects and drug resistance. To overcome these limits, many other platinum-containing drugs have been synthesised [1]. However, recently, the research of metal-based anticancer drugs has focused on other transition metal ions, as copper, ruthenium and gold. Some ruthenium compounds cause less side effects with respect to the platinum drug and are selective for cancer cells [2], on this basis, ruthenium complexes might replace the cisplatin as anticancer drug. With the purpose to design and prepare new ruthenium (III) compounds with cytotoxic activities, we prepared new complexes containing 1,10-phenanthroline derivatives and N,N’-substituted-imidazolidine-2-thione as auxiliary ligands (Fig.1). The nitrogen and thionic ligands were chosen because analogous complexes with Cu(II) show a high cytotoxic activity against mouse neuroblastoma and human tumor cell lines [3, 4, 5].The complex formation constants of the synthesised Ru(III) complexes were determined by spectrophotometric and potentiometric titrations in water solution at 25 °C and 37 °C in 0.1 M NaCl as ionic strength. The antiproliferative activity of complexes and ligands was tested in normal (skin fibroblasts, CRL-7065) and cancer derived (prostate carcinoma, DU-145; hepatocellular carcinoma, HEP-G2; squamous cell lung carcinoma, SK-MES-1;acute T-lymphoblastic leukaemia, CCRF-CEM; acute B-lymphoblastic leukaemia, CCRF-SB) human cells. In this work the preliminary results about synthesis, solution equilibria and cytotoxic activities are presented

    SHOWCAVE: a multidisciplinary research project to quantify and mitigate the environmental impacts in tourist caves

    No full text
    Over the past decades, interest for the underground karst environments has grown remarkably, not only from the scientific viewpoint, but also from an economic perspective. The so-called “show caves” are caves open to the public for touristic purposes, managed by a governmental or commercial organization. The numbers of visitors (up to 500,000/year/cave) and the profits deriving from such activities have recently gained importance worldwide. The research project of relevant national interest (PRIN 2017) “SHOWCAVE”, aims at providing an in-depth characterization of the environmental impacts related to tourist exploitation in the major Italian show caves. During the first year of the project, 12 Italian show caves were chosen as ideal setting to develop the core of the research program, i.e. the multidisciplinary evaluation of tourism impacts based on a wide set of indicators, encompassing all the abiotic and biotic components. By adopting innovative techniques and original methods, the different research units are currently monitoring: i) physical indicators, namely water and air parameters; ii) geological indicators, such asthe alterations of the carbonate rocks; iii) biological indicators, including invertebrates, lampenflora and the microbiota; iv) palaeontological and archaeological indicators. Side researches are being performed on the contamination by lint, the description of the natural heritage of Italian show caves and the human perception of the tourism impacts in the subterranean environment. The development of the first LCA (Life Cycle Assessment) method to comprehensively evaluate the impacts of the touristic service offered by show caves, together with a review of available literature on show caves, are also being carried out. Preliminary results have already been disseminated in several public engagement and educational activities. At the end, the results obtained by all the research activities will be combined to develop general protection measures and provide specific suggestions for the sustainable use of show caves
    corecore